ArticleAnalytical and bioanalytical chemistry2026
Innovative hybrid molecularly imprinted sensor for the detection of the antioxidant biomarker catalase.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a novel hybrid molecularly imprinted polymer (MIP)-based biomimetic sensor was fabricated, optimized, characterized, and applied for the electrochemical recognition of catalase (CAT), an antioxidant biomarker. A layer-by-layer approach was followed to prepare the hybrid sensor. First, silver nanoparticles (AgNPs) were deposited by chronoamperometry on a bare glassy carbon electrode (GCE) for 300 s, followed by drop-casting of multi-walled carbon nanotubes (MWCNTs). The MIP was then produced by ten voltammetric electropolymerization cycles using ortho-aminophenol (OAP) as a functional monomer in the presence of catalase as a template on the MWCNT/AgNP/GCE surface at a potential range of -0.2 V to 0.8 V. The fabricated sensor exhibited a rapid response toward CAT within a linear range of 25-500 U/mL and a limit of detection (LOD) of 3.59 U/mL, with no cross-reactivity toward several tested possible biological species. CAT was also successfully detected in biological samples, with recovery percentages ranging from 95.73% to 101.60% and relative standard deviation (RSD) of 0.41-1.52%, which is comparable to the results for a commercial diagnostic reference kit, without the need for complicated sampling procedures. The sensor performance is dependent on catalase molecular recognition rather than reactivity towards its substrate. This feature, in addition to the sensor's low cost and portability, positions it as a promising candidate for use in point-of-care diagnostics in the medical field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.